Drug Shortage Report for IMOVAX RABIES RABIES VACCINE INACTIVATED (DCO)

Last updated on 2017-12-02 History
Report ID 3035
Drug Identification Number 01908286
Brand name IMOVAX RABIES RABIES VACCINE INACTIVATED (DCO)
Common or Proper name Rabies Vaccine Inactivated (DCO)
Company Name SANOFI PASTEUR LIMITED
Active Ingredient(s) RABIES VACCINE INACTIVATED
Strength(s) 2.5UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 1.0 mL single dose vial with 1 mL diluent / Fiole de 1,0 mL à dose unique avec 1 mL de diluant
ATC code J07BG
ATC description VIRAL VACCINES
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2017-11-22
Actual start date 2017-11-22
Estimated end date 2017-12-15
Actual end date 2017-12-01
Shortage status Resolved
Updated date 2017-12-02
Company comments Sanofi Pasteur has been experiencing a supply shortage of IMOVAX® Rabies vaccine. We anticipate resuming supply by mid-December 2017.
Health Canada comments
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 416-667-2611 or 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2779 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2017-12-02 English Compare
v13 2017-12-01 French Compare
v12 2017-12-01 English Compare
v11 2017-11-23 English Compare
v10 2017-11-22 French Compare
v9 2017-11-22 English Compare
v8 2017-10-21 French Compare
v7 2017-10-21 English Compare
v6 2017-03-17 English Compare
v5 2017-03-16 French Compare
v4 2017-03-16 English Compare
v3 2017-03-16 French Compare
v2 2017-03-16 English Compare
v1 2017-03-16 English Compare